NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Plus Severe Cold and Flu PowerFast Fizz | CHLORPHENIRAMINE MALEATE, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE | R J General Corporation | d786ae07-ce57-44c7-9ba5-f4c87df115de | 2025-11-17 | Warnings | 362O9ITL9D |
| TYLENOL COLD AND FLU | ACETAMINPHEN | R J General Corporation | b618877b-9dbc-4ba2-be2c-bf1922c646cc | 2025-11-17 | Warnings | 362O9ITL9D |
| TYLENOL SINUS SEVERE | ACETAMINOPHEN | R J General Corporation | 2cbf7954-b28f-4d7b-b142-6c6c5c58b25d | 2025-11-17 | Warnings | 362O9ITL9D |
| MOTRIN IB | IBUPROFEN | R J General Corporation | afa87bb5-7fcb-4ccd-acac-f7931242181f | 2025-11-17 | Warnings | M013 |
| TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | 99e45e83-37a3-44df-9a2a-98ba7457a5bb | 2025-11-17 | Warnings | M013 362O9ITL9D |
| TYLENOL PM EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | a40ea0e3-d666-4605-b5e0-beeaf8f586f2 | 2025-11-17 | Warnings | M013 362O9ITL9D |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG | R J General Corporation | 68d3be55-9340-4cc9-a05a-12b9338ddc56 | 2025-11-17 | Warnings | M013 362O9ITL9D |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | dd9aaf80-6c2b-41a3-87b9-61642aaed4f0 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c18a2da-1718-4c00-aea8-9fb4a3418312 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | cd3060a5-3b90-42e4-89cd-3b620859045f | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c7221ae-52d1-4d18-b586-c47ff656150d | 2025-11-17 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | R J General Corporation | 907c89e7-2482-465f-9f85-2381ecab1b86 | 2025-11-17 | Warnings | M013 362O9ITL9D |
| Theraflu Severe Cold Relief Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | R J General Corporation | 8f0e4876-6bf0-4f6d-9cf0-f2aef2682ffc | 2025-11-17 | Warnings | 362O9ITL9D |
| Bayer Genuine Aspirin | ASPIRIN | R J General Corporation | 23daa359-d40f-4f64-81be-6d154f41df9f | 2025-11-17 | Warnings | M013 |
| EXTRA STRENGTH PAIN RELIEVER | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Geri-Care Pharmaceutical Corp | b670a898-2360-76e2-e053-2a95a90a3380 | 2025-11-17 | Warnings | M013 362O9ITL9D |
| Multi-Symptom Flu HBP | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 50f3157b-5788-4b63-835a-e60c8dc33df9 | 2025-11-17 | Warnings | 362O9ITL9D |
| Tramadol Hydrochloride and Acetaminophen | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | Aurobindo Pharma Limited | 6c2894df-eeeb-4b22-ab32-8ce1601bfdfa | 2025-11-17 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | L.N.K. International, Inc. | ec902e52-0f48-4a61-b67d-17e1c1461619 | 2025-11-15 | Warnings | M013 362O9ITL9D |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Chain Drug Marketing Association, Inc. | 5f8f9644-48c5-4556-a0a4-7bdc9a629daa | 2025-11-15 | Warnings | 362O9ITL9D |
| Sinus Pressure, Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | f701a6ae-200d-48dc-94e4-6bd3228f50d4 | 2025-11-15 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.